ArticleOncotarget2018

BCL2 and BCL(X)L selective inhibitors decrease mitochondrial ATP production in breast cancer cells and are synthetically lethal when combined with 2-deoxy-D-glucose.

Federico Lucantoni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.